Biologics, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Ribonucleic Acid (RNA) / May 18, 2017

Viruses Blasting Cancer

View Post

Cancer, Clinical Trials, Cocktail Fodder, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Small Molecule Drugs, Term of the Week, The WEEKLY / March 23, 2017

The Intrigue Of HIF

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / March 16, 2017

The Mechanics Of Melanoma

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Easily Confused, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs / March 9, 2017

Therapeutic Antibody Primer

View Post

Clinical Trials, Diabetes, Drug Development, Drug Targets, Mechanism of Action, Term of the Week / November 10, 2016

The Molecular Cause Of Obesity

View Post

Biologics, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies / September 29, 2016

A Bone To Pick With Osteoporosis

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Cocktail Fodder, Drug Approvals, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / July 7, 2016

Breaking Bad With NSCLC & SCLC

View Post

Biologics, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, The WEEKLY / June 23, 2016

Biotech In Space!

View Post

Biologics, Cardiovascular Disease, Drug Approvals, FDA, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / January 7, 2016

Orphan Drugs Lead 2015 Approvals

View Post

Biologics, Cancer, Drug Approvals, Drug Targets, FDA, Mechanism of Action, The WEEKLY / November 12, 2015

Cancer Immunotherapy Goes Viral

View Post

Biologics, Cancer, Clinical Trials, Cocktail Fodder, Deoxyribonucleic Acid (DNA), Drug Targets, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / September 29, 2015

Breaking Down Lung Cancer

View Post

Biologics, Business of Biotech, Cardiovascular Disease, Clinical Trials, Drug Approvals, Drug Development, Drug Targets, FDA, Mechanism of Action, Monoclonal Antibodies, Ribonucleic Acid (RNA), The WEEKLY / September 2, 2015

RNAi Crashes The PCSK9 Party

View Post

Biologics, Business of Biotech, Cardiovascular Disease, Clinical Trials, Drug Development, Drug Targets, Easily Confused, FDA, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / June 25, 2015

Potential Of PCSK9 Inhibitors

View Post

Biologics, Biotech Basics, Drug Targets, Mechanism of Action, Monoclonal Antibodies, The WEEKLY / May 7, 2015

Packing A Punch With The Immune System

View Post

Biologics, Cancer, Clinical Trials, Cocktail Fodder, Drug Development, Drug Targets, HIV, Mechanism of Action, The WEEKLY / March 19, 2015

The Power Of Oncolytic Viruses

View Post

Biologics, Biomanufacturing, Biosimilars, Business of Biotech, Drug Approvals, FDA, Mechanism of Action, Term of the Week, The WEEKLY / March 12, 2015

Interchangability Denied To First US Approved Biosimilar

View Post